EUROLAB
usp-39-microbiological-quality-of-compounding-pharmacies
Pharmaceutical Microbiology Testing ICH Q10 Pharmaceutical Quality System and Microbial ControlsICH Q6A Testing for Microbiological Attributes of Drug SubstancesICH Q7 GMP Guidelines for Microbial Control in APIsICH Q9 Risk-Based Approach to Microbial ContaminationISO 11737-1 Bioburden Testing for Medical Devices and Pharmaceutical PackagingISO 11737-2 Sterility Assurance and Validation for Pharmaceutical ComponentsISO 11930 Preservation Efficacy Testing for Topical PharmaceuticalsISO 14644-1 Cleanroom Classification for Pharmaceutical ManufacturingISO 14698-1 Biocontamination Control in CleanroomsISO 16212 Yeast and Mold Testing in Pharmaceutical Raw MaterialsISO 18415 Detection of Pathogenic Microorganisms in Non-Sterile ProductsISO 21149 Enumeration of Aerobic Mesophilic Bacteria in Cosmetic and PharmaJP XVII Bacterial Endotoxin Test for Injectable PharmaceuticalsJP XVII Microbial Limit Tests for Oral PreparationsJP XVII Sterility Test for Pharmaceutical ProductsPh. Eur. 2.6.1 Sterility Testing for Finished Pharmaceutical ProductsPh. Eur. 2.6.11 Detection of Pathogens in Veterinary PharmaceuticalsPh. Eur. 2.6.12 Microbial Contamination Testing of Non-Sterile ProductsPh. Eur. 2.6.13 Detection of Clostridia in Parenteral SolutionsPh. Eur. 2.6.14 Bacterial Endotoxins – Gel Clot MethodPh. Eur. 2.6.15 Test for Pseudomonas aeruginosa in Topical DrugsPh. Eur. 2.6.16 Test for Staphylococcus aureus in Creams and GelsPh. Eur. 2.6.2 Mycoplasma Detection in Cell-Based PharmaceuticalsPh. Eur. 2.6.25 Testing for Anaerobic Bacteria in Sterile ProductsPh. Eur. 2.6.27 Bacterial Endotoxin Testing in Parenteral DrugsPh. Eur. 2.6.30 Monitoring of Controlled EnvironmentsPh. Eur. 2.6.32 Control of Bacterial Contamination in Ophthalmic DrugsPh. Eur. 2.6.7 Mycobacteria Detection in BiopharmaceuticalsPh. Eur. 2.6.9 Test for Escherichia coli in Non-Sterile PharmaPh. Eur. 5.1.4 Microbiological Quality of Pharmaceutical PreparationsPh. Eur. 5.1.6 Alternative Methods for Microbiological Quality ControlPh. Eur. 5.1.8 Bioburden Limits in Parenteral ManufacturingUSP <1072> Disinfectants and Antiseptics Microbial Efficacy TestUSP <1111> Microbiological Examination of Non-Sterile ProductsUSP <1115> Bioburden Control of Non-Sterile Drug SubstancesUSP <1116> Microbiological Control of Clean Rooms and Controlled EnvironmentsUSP <1117> Microbial Best Practices for Pharmaceutical Lab PersonnelUSP <1207> Package Integrity Evaluation – Microbial Ingress TestUSP <1208> Integrity Testing for Sterile Barrier SystemsUSP <1223> Water Activity Determination in Drug ProductsUSP <1227> Validation of Microbial Recovery MethodsUSP <1229> Microbial Quality of Compendial Water SystemsUSP <1231> Water for Pharmaceutical Purposes – Microbiological TestingUSP <39> Bioburden Limit Testing for Bulk Active IngredientsUSP <51> Preservative Effectiveness Testing of Multi-Dose PharmaceuticalsUSP <55> Biological Indicators for Sterilization ValidationUSP <61> Microbial Enumeration Tests for Raw Pharmaceutical MaterialsUSP <61>/<62> Microbial Limit Tests for Tablet and Capsule FormsUSP <62> Tests for Specified Microorganisms in Non-Sterile ProductsUSP <71> Sterility Testing of Injectable Pharmaceutical Products

USP <39> Microbiological Quality of Compounding Pharmacies: Eurolabs Laboratory Testing Service

1.1 Overview of Relevant Standards

The United States Pharmacopeia (USP) is a non-profit organization that develops and publishes standards for the pharmaceutical industry. USP <39> Microbiological Quality of Compounding Pharmacies is a standard that outlines the requirements for microbiological testing in compounding pharmacies.

Other relevant standards include:

  • ISO 17025:2005 General Requirements for the Competence of Testing and Calibration Laboratories
  • ASTM E2856-18 Standard Practice for Validation of Laboratory Information Management Systems (LIMS)
  • EN 14698:2019 Microbiological examination of non-sterile pharmaceutical products
  • 1.2 Legal and Regulatory Framework

    The compounding pharmacy industry is heavily regulated by the US FDA, which enforces standards such as USP <39> to ensure product safety and quality.

    Regulatory Requirements

  • US FDA regulations (21 CFR Part 211) require compounding pharmacies to perform microbiological testing on their products.
  • USP <39> outlines specific requirements for microbiological testing in compounding pharmacies, including sampling plans, test methods, and reporting formats.
  • 1.3 Standard Development Organizations

    The following organizations play a crucial role in the development of standards for laboratory testing:

  • International Organization for Standardization (ISO)
  • American Society for Testing and Materials (ASTM)
  • European Committee for Standardization (CEN)
  • Standard Evolution

    Standards are constantly evolving to reflect advances in technology, changes in regulatory requirements, and new scientific discoveries.

    1.4 Industry-Specific Standards

    Each industry has its own set of standards that must be followed when conducting laboratory testing:

  • Pharmaceutical: USP <39>, ISO 17025
  • Food and Beverage: FDA regulations (21 CFR Part 110), ASTM E2856-18
  • Cosmetics: FDA regulations (21 CFR Part 701), ISO 17025
  • Industry Compliance Requirements

    Each industry has its own set of compliance requirements, including:

  • Sampling plans
  • Test methods
  • Reporting formats
  • 1.5 Accreditation and Certification

    Accreditation and certification are essential for laboratory testing services to ensure they meet industry standards.

    Accreditation

    Eurolab is accredited by a recognized accrediting body (e.g., A2LA) to ISO 17025:2005 General Requirements for the Competence of Testing and Calibration Laboratories.

    1.6 International Standards

    International standards are essential for laboratory testing services to ensure they meet global requirements:

  • ISO 17025:2005
  • EN 14698:2019
  • ASTM E2856-18
  • Summary

    USP <39> Microbiological Quality of Compounding Pharmacies is a standard that outlines the requirements for microbiological testing in compounding pharmacies. The industry is heavily regulated by the US FDA, which enforces standards such as USP <39>. Eurolab is accredited to ISO 17025:2005 and follows international standards to ensure compliance.

    2.1 Business and Technical Reasons for Testing

    Conducting microbiological testing on compounding pharmacy products ensures product safety and quality:

  • Risk Assessment: Compounding pharmacies must assess the risk of microbial contamination in their products.
  • Quality Assurance: Microbiological testing is essential to ensure the quality of products.
  • 2.2 Consequences of Not Performing This Test

    Failure to conduct microbiological testing can result in:

  • Product Recalls
  • Regulatory Action
  • Loss of Business and Reputation
  • 2.3 Industries and Sectors that Require Testing

    Microbiological testing is required for:

  • Compounding pharmacies
  • Pharmaceutical manufacturers
  • Food and beverage manufacturers
  • Cosmetic manufacturers
  • Risk Factors and Safety Implications

  • Microbial contamination can lead to serious health issues, including infection and death.
  • Failure to detect microbial contamination can result in product recalls and regulatory action.
  • 2.4 Quality Assurance and Control Aspects

    Eurolabs quality assurance and control procedures ensure:

  • Sampling plans are designed to detect microbial contamination
  • Test methods are validated to ensure accuracy and reliability
  • Reporting formats meet industry requirements
  • Summary

    Conducting microbiological testing on compounding pharmacy products ensures product safety and quality. Failure to conduct this test can result in regulatory action, loss of business and reputation, and serious health issues.

    3.1 Testing Equipment and Instruments

    Eurolab uses state-of-the-art equipment and instruments for microbiological testing:

  • Sterile air incubators
  • Microbiological analyzers
  • Sampling equipment
  • 3.2 Sampling Plans

    Eurolab designs sampling plans to detect microbial contamination:

  • Random sampling
  • Targeted sampling
  • Comprehensive sampling
  • Test Methods

    Eurolab uses validated test methods for microbiological testing:

  • Microbial enumeration
  • Antimicrobial efficacy testing
  • Endotoxin testing
  • 3.4 Reporting Formats

    Eurolabs reporting formats meet industry requirements:

  • Standardized reporting templates
  • Electronic data submission
  • Summary

    Eurolab uses state-of-the-art equipment and instruments for microbiological testing, designs sampling plans to detect microbial contamination, uses validated test methods, and meets industry reporting requirements.

    4.1 Overview of Accreditation and Certification

    Accreditation and certification are essential for laboratory testing services to ensure they meet industry standards:

  • Accreditation: Recognition by a recognized accrediting body
  • Certification: Demonstration of competence in specific areas
  • Eurolabs Accreditation and Certification

    Eurolab is accredited by a recognized accrediting body (e.g., A2LA) to ISO 17025:2005 General Requirements for the Competence of Testing and Calibration Laboratories.

    Summary

    Accreditation and certification are essential for laboratory testing services. Eurolab meets industry standards through accreditation and certification, ensuring compliance with regulations and industry requirements.

    This is a comprehensive guide to Eurolabs laboratory testing service for USP <39> Microbiological Quality of Compounding Pharmacies.

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    Latest News

    View all

    JOIN US
    Want to make a difference?

    Careers